Search

Advances in diagnostic and imaging modalities are making it possible to detect complex melanoma earlier, with greater accuracy, and are helping guide surgical approaches and patient monitoring plans.

… Wednesday, October 12, 2016 Early detection of melanoma is paramount to determine the best treatment approach and achieve a potential cure. Advances in diagnostic and imaging modalities are making it possible to detect melanoma earlier, with greater accuracy, and are helping guide surgical approaches

Three emerging investigators are tackling the mysteries of biology and cancer at Memorial Sloan Kettering.

… Monday, April 1, 2013 Summary Three emerging investigators are tackling the mysteries of biology and cancer at Memorial Sloan Kettering. Can studying zebrafish lead someday to new cancer treatments? How can poxviruses be used to cause tumor cell death? What do leukemia cells have in common with the stem

There is a clear and unmet need for less invasive and more accurate methods for diagnosing lung cancer. A promising innovation under investigation at Memorial Sloan Kettering Cancer Center (MSK) is the electronic nose (e-nose), which evaluates volatile organic compounds (VOCs) in exhaled breath. The e-nose platform detects a lung cancer-associated “breathprint” in breath from individuals with lung cancer.

… Friday, September 15, 2023 There is a clear and unmet need for less invasive and more accurate methods for diagnosing lung cancer. A promising innovation under investigation at Memorial Sloan Kettering Cancer Center (MSK) is the electronic nose (e-nose), which evaluates volatile organic compounds (VOCs

MSK researchers shed light on how the number of mutations in a tumor affect a patient’s response to immunotherapy drugs.

… Monday, February 22, 2021 Summary The level of genetic mutations in a tumor, called tumor mutational burden (TMB), has been used to predict how people with cancer will respond to immunotherapy. But MSK physician-scientist Luc Morris explains that important aspects of TMB’s clinical relevance have needed

Find out why you still need your routine mammogram, even during COVID-19.

… Wednesday, October 6, 2021 At a time when too many women delayed their yearly mammogram because of the pandemic, Katie Gay is very glad she did not miss hers. She knew that because of her dense breasts, regular screenings were critical. After her routine mammogram in February 2021, Katie found out she

Learn about Madeleine Ruff’s inspiring story, from being treated at MSK Kids for a rare cancer as a teenager to managing clinical trials for new cancer treatments as an adult.

… Monday, June 10, 2024 Madeleine Ruff, MHA, helps manage  clinical trials that test new cancer treatments to see how well they work. It’s an important job but one that doesn’t seem all that unusual, until you learn that Maddy started her career as a professional rock ’n’ roll and jazz singer. It’s certainly

Based a clinical trial conducted at MSK, the FDA has approved the targeted drug cobimetinib (Cotellic®) for treating a rare group of diseases known as histiocytoses, or histiocytic neoplasms in adults.

… Monday, January 30, 2023 Based a clinical trial conducted at MSK, the FDA has approved the targeted drug cobimetinib (Cotellic®) for treating a rare group of diseases known as histiocytoses, or histiocytic neoplasms in adults. For years, Robin Bankins had chronic sinus pain — one of the effects of Rosai-Dorfman

In order for immune cells to effectively kill cancer cells, a triad of three cells are necessary — a dendritic cell, a cytotoxic “killer” T cell, and a helper T cell, researchers at MSK and Baylor College of Medicine have found. The discovery could alter the way doctors administer immunotherapies.

… Monday, July 15, 2024 There’s a frustrating fact about today’s immunotherapies for cancer . While sometimes they work beautifully — completely eliminating or greatly reducing cancer in particular patients — other times they don’t work at all. It’s a mystery. Scientists have posed several hypotheses to

Learn how a new imaging approach lights up nerves so they can be avoided during prostate cancer surgery.

… Wednesday, July 9, 2025 Men having  prostate cancer  surgery often fear  side effects  that can result from the procedure. Removing the tumor risks damage to surrounding nerves, resulting in erectile dysfunction and incontinence. Now a new way to light up nerves during the operation may help surgeons

Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS) can convert to high-risk MGUS and progress to multiple myeloma within a five-year window. This research clinically supports recommendations for annual blood tests for all individuals diagnosed with MGUS along with re-assessments of a patient’s clinical-risk status. Their research was published today online in JAMA Oncology.

… Thursday, July 18, 2019 Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS ) can convert to high-risk MGUS and progress